cethromycin   Click here for help

GtoPdb Ligand ID: 10791

Synonyms: A-195773 | Abbott-195773 | ABT-773 | ABT773 | Restanza®
PDB Ligand
Compound class: Synthetic organic
Comment: Cethromycin is an orally bioavailable ketolide antibacterial that is structurally related to erythromycin. It was developed by Abbott Laboratories for potential to treat respiratory infections, including community acquired pneumonia (CAP) and for the prevention of post-exposure inhalational anthrax [1-2].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 13
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 162.82
Molecular weight 765.42
XLogP 3.52
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C[C@H](C(=O)[C@@H]([C@@H]2[C@]1(C)OC(=O)N2)C)C)(C)OC/C=C/c1cnc2c(c1)cccc2
Isomeric SMILES CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C[C@H](C(=O)[C@@H]([C@@H]2[C@]1(C)OC(=O)N2)C)C)(C)OC/C=C/c1cnc2c(c1)cccc2
InChI InChI=1S/C42H59N3O10/c1-11-32-42(8)36(44-40(50)55-42)25(4)33(46)23(2)21-41(7,51-18-14-15-28-20-29-16-12-13-17-30(29)43-22-28)37(26(5)34(47)27(6)38(49)53-32)54-39-35(48)31(45(9)10)19-24(3)52-39/h12-17,20,22-27,31-32,35-37,39,48H,11,18-19,21H2,1-10H3,(H,44,50)/b15-14+/t23-,24-,25+,26+,27-,31+,32-,35-,36-,37-,39+,41-,42-/m1/s1
InChI Key PENDGIOBPJLVBT-ONLVEXIXSA-N
References
1. Hammerschlag MR, Sharma R. (2008)
Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections.
Expert Opin Investig Drugs, 17 (3): 387-400. [PMID:18321237]
2. Rafie S, MacDougall C, James CL. (2010)
Cethromycin: a promising new ketolide antibiotic for respiratory infections.
Pharmacotherapy, 30 (3): 290-303. [PMID:20180612]